FDx Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,499
| Closed | -$989K | – | 356 |
|
|
2024
Q1 | $989K | Sell |
2,499
-494
| -17% | -$196K | 0.15% | 134 |
|
|
2023
Q4 | $1.05M | Sell |
2,993
-489
| -14% | -$172K | 0.08% | 239 |
|
|
2023
Q3 | $1.31M | Sell |
3,482
-980
| -22% | -$368K | 0.11% | 182 |
|
|
2023
Q2 | $1.71M | Buy |
4,462
+1,272
| +40% | +$487K | 0.09% | 208 |
|
|
2023
Q1 | $751K | Hold |
3,190
| – | – | 0.03% | 351 |
|
|
2022
Q4 | $751K | Buy |
3,190
+546
| +21% | +$129K | 0.03% | 351 |
|
|
2022
Q3 | $651K | Sell |
2,644
-2,668
| -50% | -$657K | 0.03% | 363 |
|
|
2022
Q2 | $1.61M | Sell |
5,312
-489
| -8% | -$148K | 0.06% | 239 |
|
|
2022
Q1 | $2.38M | Sell |
5,801
-1,322
| -19% | -$543K | 0.08% | 192 |
|
|
2021
Q4 | $3.34M | Sell |
7,123
-325
| -4% | -$152K | 0.09% | 162 |
|
|
2021
Q3 | $3.16M | Buy |
7,448
+636
| +9% | +$270K | 0.1% | 154 |
|
|
2021
Q2 | $2.45M | Buy |
6,812
+898
| +15% | +$322K | 0.08% | 173 |
|
|
2021
Q1 | $1.67M | Buy |
5,914
+590
| +11% | +$166K | 0.06% | 199 |
|
|
2020
Q4 | $1.51M | Buy |
5,324
+1,077
| +25% | +$305K | 0.06% | 202 |
|
|
2020
Q3 | $1.17M | Buy |
4,247
+2,626
| +162% | +$722K | 0.05% | 215 |
|
|
2020
Q2 | $368K | Sell |
1,621
-362
| -18% | -$82.2K | 0.02% | 400 |
|
|
2020
Q1 | $302K | Sell |
1,983
-37
| -2% | -$5.64K | 0.02% | 381 |
|
|
2019
Q4 | $304K | Sell |
2,020
-62
| -3% | -$9.33K | 0.02% | 481 |
|
|
2019
Q3 | $295K | Sell |
2,082
-6,467
| -76% | -$916K | 0.02% | 487 |
|
|
2019
Q2 | $1.07M | Buy |
8,549
+1,220
| +17% | +$153K | 0.04% | 307 |
|
|
2019
Q1 | $808K | Buy |
7,329
+4,805
| +190% | +$530K | 0.03% | 348 |
|
|
2018
Q4 | $247K | Sell |
2,524
-4,454
| -64% | -$436K | 0.02% | 467 |
|
|
2018
Q3 | $862K | Buy |
6,978
+1,980
| +40% | +$245K | 0.03% | 371 |
|
|
2018
Q2 | $496K | Buy |
4,998
+215
| +4% | +$21.3K | 0.02% | 551 |
|
|
2018
Q1 | $422K | Sell |
4,783
-1,995
| -29% | -$176K | 0.01% | 843 |
|
|
2017
Q4 | $669K | Sell |
6,778
-326
| -5% | -$32.2K | 0.02% | 684 |
|
|
2017
Q3 | $684K | Buy |
7,104
+236
| +3% | +$22.7K | 0.02% | 662 |
|
|
2017
Q2 | $649K | Buy |
6,868
+4,262
| +164% | +$403K | 0.02% | 671 |
|
|
2017
Q1 | $213K | Buy |
+2,606
| New | +$213K | 0.01% | 1104 |
|
|
2016
Q3 | – | Sell |
-7,952
| Closed | -$603K | – | 952 |
|
|
2016
Q2 | $603K | Sell |
7,952
-1,911
| -19% | -$145K | 0.03% | 529 |
|
|
2016
Q1 | $684K | Sell |
9,863
-238
| -2% | -$16.5K | 0.03% | 492 |
|
|
2015
Q4 | $608K | Buy |
10,101
+1,640
| +19% | +$98.7K | 0.03% | 500 |
|
|
2015
Q3 | $458K | Sell |
8,461
-1,676
| -17% | -$90.7K | 0.04% | 480 |
|
|
2015
Q2 | $589K | Sell |
10,137
-1,663
| -14% | -$96.6K | 0.03% | 515 |
|
|
2015
Q1 | $713K | Sell |
11,800
-8,036
| -41% | -$486K | 0.02% | 753 |
|
|
2014
Q4 | $1.06M | Sell |
19,836
-1,137
| -5% | -$60.5K | 0.06% | 282 |
|
|
2014
Q3 | $939K | Buy |
20,973
+3,880
| +23% | +$174K | 0.06% | 348 |
|
|
2014
Q2 | $721K | Buy |
17,093
+1,303
| +8% | +$55K | 0.05% | 440 |
|
|
2014
Q1 | $696K | Buy |
15,790
+7,619
| +93% | +$336K | 0.06% | 339 |
|
|
2013
Q4 | $401K | Sell |
8,171
-91
| -1% | -$4.47K | 0.04% | 420 |
|
|
2013
Q3 | $340K | Buy |
+8,262
| New | +$340K | 0.04% | 392 |
|